|
Implementation of Ischemic Heart Disease Clinical Practice Guidelines Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Implementation of Ischemic Heart Disease Clinical Practice Guidelines conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Implementation of Ischemic Heart Disease Clinical Practice Guidelines Clinical research trials and Implementation of Ischemic Heart Disease Clinical Practice Guidelines healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Implementation of Ischemic Heart Disease Clinical Practice Guidelines. Implementation of Ischemic Heart Disease Clinical Practice Guidelines Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Implementation of Ischemic Heart Disease Clinical Practice Guidelines clinical trial. Test subjects typically receive the most effective healthcare possible for their Implementation of Ischemic Heart Disease Clinical Practice Guidelines condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "I" Clinical Trials Conditions > Implementation of Ischemic Heart Disease Clinical Practice Guidelines  Implementation of Ischemic Heart Disease Clinical Practice Guidelines
Implementation of Ischemic Heart Disease Clinical Practice Guidelines
For Condition: Heart Disease,Myocardial Ischemia,Coronary Disease
Status: Completed
Sponsor(s): Department of Veterans Affairs , Department of Veterans Affairs Health Services Research and Development Service,Department of Veterans Affairs - Veterans Integrated Services Network
Synopsis: The purpose of this study is to design and evaluate targeted implementation strategies to fully integrate the VHA clinical practice guidelines for ischemic heart disease into VHA clinical practice. Effectively implementing the guideline will enhance the quality, appropriateness, timeliness, and cost effectiveness of care delivered to veterans with ischemic heart disease. The long-term objective of this study is to identify the best strategies for implementing the IHD guidelines to improve guideline adherence and provider acceptance. The specific objectives of the study are to: (1) describe the temporal aspects of guideline acceptance and adherence, over three periods of time: pre-implementation, post implementation of general strategies, and post- implementation of targeted strategies; (2) assess the relative effectiveness of targeted intervention strategies on guideline adherence; (3) identify the relationships among provider beliefs, attitudes, and their intentions to use guidelines; (4) identify the costs associated with implementation of general and targeted implementation strategies; and (5) describe provider satisfaction with targeted implementation strategies. Qualitative (focus groups, interviews with key informants) and quantitative methods (surveys, chart reviews) are used to address study objectives. A survey will be sent to providers to measure beliefs and attitudes that predict provider acceptance to clinical practice guidelines. Patient level data will be collected from reviews of charts from each facility. Based on provider focus groups we will design targeted strategies to overcome system barriers and address needs identified by providers to support clinical practice guideline implementation. A randomized trial will be conducted to assess the relative effectiveness of the targeted intervention strategies.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Single Blind, Active Control, Single Group Assignment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Patients: Ischemic heart patients. Providers: All physician, physician assistants and advanced registered nurse practitioners providers on medical services who are likely to care for IHD patients and who have a significant direct care responsibility greater than 35% of their time allocated to direct patient care are included. These services include cardiology, internal medicine, and ambulatory/primary care.
Total Enrollment: 9789
Location and Contact Information:
James A. Haley VA Medical Center
Tampa, Florida, 33612
United States
Additional Information:
Study ID Numbers: VCR 99-014;
Study Start Date: October 1999
Record last reviewed: October 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00013104
Other Heart Disease Studies:
1. Analysis of Heart Muscle Function in Patients with Heart Disease and Normal Volunteers
2. Open Study of enoxaparin vs. unfractionated heparin in patients with acute coronary syndromes
3. Multicenter Study of Silent Myocardial Ischemia (MSSMI)
4. Women's Angiographic Vitamin and Estrogen Trial (WAVE)
5. Electromechanical Mapping to Evaluate Heart Muscle
Related Studies:
Other Heart Disease Clinical Trials
Other Florida Clinical Trials
Other Tampa Clinical Trials
Implementation of Ischemic Heart Disease Clinical Practice Guidelines
|
|
|
|
|
|
|
|
